Target intelligence / Profile preview

PGR antisense RNA 1 (PGR-AS1)

Target
PGR-AS1
Molecular classification
Long non-coding RNA (lncRNA), Intergenic lncRNA, Antisense RNA
01

Overview

PGR antisense RNA 1 (PGR-AS1) is a long intergenic non-coding RNA transcribed from the plus strand of chromosome 11, overlapping the region of the progesterone receptor (PGR) gene. It is classified as a lincRNA with no protein-coding capacity, consisting of three exons and spanning approximately 429 base pairs. Its main biological feature is its antisense relationship with the PGR gene, which may enable it to regulate PGR expression at the transcriptional or post-transcriptional level—a general role observed in antisense RNAs. To date, no specific functional studies or disease roles have been well established for PGR-AS1, and no drugs or biomarkers have been linked to it. It is not a conventional therapeutic target, and its molecular function and clinical relevance remain largely unexplored[1][5][7].

Other names
AT1AT2AT3PR-antisense-transcriptsNONHSAT023852RP11-788M5.4FPKM1_group_5210_transcript_1ENST00000531772.1ENSG00000282728.1
02

Mechanism of action

Not applicable. There are no drugs targeting PGR-AS1, so mechanisms of action are undefined.

03

Biological functions

Regulation of gene expression (through antisense interaction with PGR mRNA)Potential role in transcriptional interference and RNA stability (general for antisense RNAs, specific role for PGR-AS1 is largely uncharacterized)
04

Disease associations

No well-established direct associations with specific diseases.General lncRNAs and antisense RNAs can have roles in cancer, gene regulation, and cell cycle, but there is no clear evidence for PGR-AS1.

Beyond the preview

Go deeper on PGR antisense RNA 1 (PGR-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PGR antisense RNA 1 (PGR-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call